🇺🇸 Pregabalin 25 MG in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bradycardia — 2 reports (15.38%)
  2. Chest Discomfort — 2 reports (15.38%)
  3. Dizziness — 2 reports (15.38%)
  4. Abscess — 1 report (7.69%)
  5. Accidental Exposure — 1 report (7.69%)
  6. Agitation — 1 report (7.69%)
  7. Blood Calcium Increased — 1 report (7.69%)
  8. Blood Potassium Increased — 1 report (7.69%)
  9. Drug Ineffective — 1 report (7.69%)
  10. Dyspnoea — 1 report (7.69%)

Source database →

Pregabalin 25 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Pregabalin 25 MG approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pregabalin 25 MG in United States?

Ajou University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.